P157 Synergistic effect of anti-blood group A/B AND-HLA antibodies in kidney transplnatation

2019 ◽  
Vol 80 ◽  
pp. 179
Author(s):  
Hyunwook Kwon ◽  
Dong Hyun Kim ◽  
Youngmin Ko ◽  
Young Hoon Kim
2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Hyunwook Kwon ◽  
◽  
Jee Yeon Kim ◽  
Dong Hyun Kim ◽  
Youngmin Ko ◽  
...  

AbstractABO-incompatible (ABOi) and positive crossmatch (XM) kidney transplantation (KT) have been considered immunologically challenging. The present study analyzed the clinical outcomes in XM positive KT based on ABO incompatibility. We used data from the Korea Organ Transplantation Registry, a nationwide database, and a single-center registry. A total of 263 patients with positive XM were divided into an ABO compatible (ABOc) & XM positive (ABOc/XM+, n = 176) group and an ABOi & XM positive (ABOi/XM+, n = 87) group. The overall rejection rate one year after KT was significantly higher in the ABOi/XM+ group than in the ABOc/XM+ group (P < 0.01). A total of four mortalities occurred, all in the ABOi/XM+ patients (P < 0.01). There were no differences in surgical complications or the occurrence of infection-related complications, including BK virus nephropathy. Multivariate analysis indicated that female vs. male (odds ratio (OR), 2.27; P = 0.03), DSA class I (MFI/1000) (OR, 1.10; P = 0.03), DSA class II (MFI/1000) (OR, 1.10; P < 0.01), and ABOi & XM+ status (OR, 2.38; P < 0.01) were significant risk factors for acute rejection during the year after transplantation. Overall graft survival was inferior in ABOi/XM+ patients than in ABOc/XM+ patients (P = 0.02). ABO incompatibility in XM-positive KT patients was found to be a significant risk factor for the development of rejection within one year after transplantation as well as for long-term graft survival. The anti-blood group A, B and anti-HLA antibodies may show synergistic activity.


1987 ◽  
Vol 262 (29) ◽  
pp. 14228-14234
Author(s):  
H Clausen ◽  
S B Levery ◽  
E D Nudelman ◽  
M Stroud ◽  
M E Salyan ◽  
...  

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
S. Samra ◽  
M. Habeb ◽  
R. Nafae

Abstract Background A few people infected by the coronavirus become seriously ill, while others show little to no signs of the symptoms, or are asymptomatic. Recent researches are pointing to the fact that the ABO blood group might play an important role in a person’s susceptibility and severity of COVID-19 infection. Aim of the study: try to understand the relationship between ABO groups and COVID-19 (susceptibility and severity). Results A total of (507) patients were included in this study. The study population was divided based on the ABO blood group into types A+, A−, B+, AB, O+, and O−. Blood group A was associated with high susceptibility of infection: group A, 381 (75.1%); and less common in group O, 97 (19.2%), group B, 18 (3.5%), and group AB, 11 (2.2%). The severity of COVID-19 infection was common in non-blood group O where (20 (7.1%), 4 (26.7%), 2 (11%), and 1 (9%) in type A+, A−, B+, and AB, respectively), while in type O 3.1%. And mechanically ventilated patients were 22 (5.9%), 2 (13.4%), 2 (11.1%), and 1 (1%). Mortality was high in blood groups A and B, 16 (4.37%) and 1 (5.5%), respectively, while in blood group O, it was 1%. Conclusion The incidence, severity, and mortality of COVID-19 were common in non-blood group O. While blood group O was protected against COVID-19.


Transfusion ◽  
2021 ◽  
Author(s):  
Chelsea Hayes ◽  
Wesley Rubenstein ◽  
David Gibb ◽  
Ellen Klapper ◽  
Julie Tanaka ◽  
...  

2019 ◽  
Vol 51 (5) ◽  
pp. 1371-1377 ◽  
Author(s):  
Tsukasa Nakamura ◽  
Takayuki Shirouzu ◽  
Shintaro Kawai ◽  
Yui Imanishi ◽  
Takehisa Matsuyama ◽  
...  

Vox Sanguinis ◽  
1977 ◽  
Vol 33 (4) ◽  
pp. 193-201 ◽  
Author(s):  
S.P. Kent ◽  
J.M. McKibbin ◽  
R. Boggio ◽  
J.B. McKibbin
Keyword(s):  

Nature ◽  
1961 ◽  
Vol 191 (4784) ◽  
pp. 149-150 ◽  
Author(s):  
I. A. F. LISTER CHEESE ◽  
W. T. J. MORGAN

Sign in / Sign up

Export Citation Format

Share Document